Brief CBT for the Treatment of Depression During Inpatient Hospitalization
NCT ID: NCT03011619
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-04-06
2018-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
NCT03307070
Brief Inpatient Psychotherapy for Depression
NCT03091582
Detection and Treatment of Depression in Patients Admitted to the General Hospital
NCT00521911
Cognitive Control Training as an Adjunct to Behavioral Activation Therapy in the Treatment of Depression
NCT01694719
Cognitive Behavioral vs. Interpersonal Therapy (IPT) Prevention of Depression in Adolescents
NCT00374439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Condition
usual standard of care during an inpatient psychiatric hospitalization; medication management, group therapy, and individual therapy.
Usual Standard of Care
medication management, group therapy, and individual therapy.
CBT Condition
If a patient is randomly assigned to the enhanced CBT group, they will participate in manualized CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.
Usual Standard of Care
medication management, group therapy, and individual therapy.
Cognitive Behavioral Therapy Condition (CBT)
CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Usual Standard of Care
medication management, group therapy, and individual therapy.
Cognitive Behavioral Therapy Condition (CBT)
CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Demonstrates at least moderate degree of depressive symptoms on MADRS, HAM-D, and CGI-S.
* Provides written informed consent.
Exclusion Criteria
* A cognitive or neurologic disorder that inhibits ability to engage in CBT.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacqueline Sergie, MD
Role: PRINCIPAL_INVESTIGATOR
NYU School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-01404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.